This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Title: Innovations in Cancer Detection by Roman Bartz
Introduction
Roman Bartz is an innovative inventor based in Germany, known for his contributions to the field of cancer detection. His work focuses on the detection of bone metastases in renal clear cell carcinoma, a significant advancement in medical diagnostics.
Latest Patents
Roman Bartz holds a patent titled "Selective Detection Of Bone Metastases In Renal Clear Cell Carcinoma." This invention refers to the detection of bone metastases in renal cell carcinoma (RCC) using a 12 4 I-labelled antibody or antigen-binding fragment directed against carbonic anhydrase IX. Although he currently has 0 patents, his research is pivotal in enhancing cancer detection methodologies.
Career Highlights
Bartz is associated with Heidelberg Pharma AG, a company dedicated to developing innovative therapies for cancer treatment. His role at the company allows him to collaborate with other experts in the field, contributing to groundbreaking research and development.
Collaborations
Roman Bartz has worked alongside notable colleagues such as Robert Uzzo and David Chen. Their combined expertise fosters a collaborative environment that drives innovation in cancer research.
Conclusion
Roman Bartz's work in cancer detection exemplifies the importance of innovation in medical science. His contributions are vital for improving diagnostic techniques and ultimately enhancing patient care.